Elevance Health Inc.
No price chart data available for 1D timeframe.
Rating
Why Price Moved
Shares are trading higher after the company reaffi...
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to v...
Latest News
2 days ago · zacks.com
Elevance Health (ELV) Is Up 2.73% in One Week: What You Should KnowDoes Elevance Health (ELV) have what it takes to be a top stock pick for momentum investors? Let's find out.
6 days ago · gurufocus.com
ELV Fairly Valued by DCF at $418On October 27, 2026, we delve into the DCF analysis for Elevance Health Inc (ELV), a company that has shown notable price performance over the past year, with a
7 days ago · zacks.com
Implied Volatility Surging for Elevance Health Stock OptionsInvestors need to pay close attention to ELV stock based on the movements in the options market lately.
11 days ago · seekingalpha.com
Elevance Health: Better Results, But Not Enough To BuyElevance Health raised its 2026 adjusted EPS guidance to at least $29, but the sustainability of its earnings recovery remains uncertain. Third-quarter adjusted EPS rose 15.9%, while nine-month operating gain declined 25.7%, highlighting the gap between improving earnings and underlying profitability. Health Benefits margins remain under pressure, particularly in Medicaid, despite improving medical cost trends and stronger quarterly results.
11 days ago · fool.com
Elevance: 3 Key Takeaways for Long-Term InvestorsElevance raised its 2026 earnings baseline to at least $26.75 per share. Carelon's cancer program reduced avoidable inpatient admissions by 15%.
12 days ago · zacks.com
Elevance Health, Inc. (ELV) Hits Fresh High: Is There Still Room to Run?Elevance Health (ELV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
12 days ago · seekingalpha.com
Elevance Health, Inc. (ELV) Q3 2026 Earnings Call TranscriptElevance Health, Inc. (ELV) Q3 2026 Earnings Call Transcript
12 days ago · zacks.com
ELV Beats Q3 Earnings Estimates on Carelon Strength, Raises 2026 OutlookElevance Health beats Q3 EPS estimate by 50% as Carelon grows despite declining medical membership, and lifts its 2026 underlying earnings baseline to $26.75.
12 days ago · marketbeat.com
What Elevance Health (ELV) Said on Its Q3 Earnings CallElevance Health NYSE: ELV raised its 2026 earnings outlook after reporting third-quarter adjusted diluted earnings per share of $6.99, exceeding the company's expectations as Medicaid, Medicare Advantage and Individual ACA businesses all performed better than anticipated.
12 days ago · zacks.com
Compared to Estimates, Elevance Health (ELV) Q3 Earnings: A Look at Key MetricsWhile the top- and bottom-line numbers for Elevance Health (ELV) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove ELV